Official SEC submissions

Latigo Biotherapeutics SEC Filings

Direct answer

Latigo Biotherapeutics's latest SEC filing is 10-Q.

It was filed on September 3, 2026, and 13 recent filings are available.
Each row links directly to the SEC document and filing index.

Get free Latigo Biotherapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Recent SEC filings

10-Q

Periodic report

Filed:

Report date:

10-Q

8-K

Current report

Filed:

Report date:

8-K

4

Insider transaction

Filed:

Report date:

4

Insider transaction

Filed:

Report date:

4

4

Insider transaction

Filed:

Report date:

OWNERSHIP DOCUMENT

4

Insider transaction

Filed:

Report date:

OWNERSHIP DOCUMENT

4

Insider transaction

Filed:

Report date:

4

Insider transaction

Filed:

Report date:

4

Insider transaction

Filed:

Report date:

8-K

Current report

Filed:

Report date:

8-K

S-1/A

Registration statement

Filed:

S-1/A

S-1/A

Registration statement

Filed:

S-1/A

S-1

Registration statement

Filed:

S-1

Verified data

Recent filing categories
4
Recent filings
13
SEC CIK
0002056611
Latest filing date
September 3, 2026